Aktienanalyse zu Tilray Brands Inc (TLRY)TLRYTilray Brands Inc

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Tilray Brands Inc is not a good buy right now due to significant financial losses and declining stock performance. The current price is $3.54, and the stock has dropped 63.58% year-to-date. Additionally, the RSI is at 26.854, indicating it is oversold, but this does not guarantee a price recovery in the near term.

3 analysts cover TLRY: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.57.